INTRODUCTION: Numerous studies have demonstrated that sleep promotes memory consolidation, but there is little research on the effect of hypnotics on sleep-dependent memory consolidation. We compared bedtime administration of zolpidem-ER 12.5 mg (6- to 8-h duration of action), middle-of-the-night administration of zaleplon 10 mg (3- to 4-h duration of action), and placebo to examine the effect of different durations of hypnotic drug exposure on memory consolidation during sleep. METHODS:Twenty-two participants with no sleep complaints underwent 3 conditions in a counterbalanced crossover study: (1) zolpidem-ER 12.5 mg (bedtime dosing), (2) zaleplon 10 mg (middle-of-the-night dosing), and (3) placebo. Memory testing was conducted before and after an 8-h sleep period, using a word pair association task (WPT; declarative memory) and a finger-tapping task (FTT; procedural memory). RESULTS: ANOVA revealed a significant condition effect for the WPT (p = 0.025) and a trend for the FTT (p = 0.067), which was significant when sex was added to the model (p = 0.014). Improvement in memory performance following sleep was lower with bedtime dosing of zolpidem-ER compared to placebo and middle-of-the-night dosing of zaleplon. There were no differences between placebo and zaleplon. CONCLUSIONS: The results suggest that in some circumstances hypnotics may have the potential to reduce the degree of sleep-dependent memory consolidation and that drug-free sleep early in the night may ameliorate this effect.
RCT Entities:
INTRODUCTION: Numerous studies have demonstrated that sleep promotes memory consolidation, but there is little research on the effect of hypnotics on sleep-dependent memory consolidation. We compared bedtime administration of zolpidem-ER 12.5 mg (6- to 8-h duration of action), middle-of-the-night administration of zaleplon 10 mg (3- to 4-h duration of action), and placebo to examine the effect of different durations of hypnotic drug exposure on memory consolidation during sleep. METHODS: Twenty-two participants with no sleep complaints underwent 3 conditions in a counterbalanced crossover study: (1) zolpidem-ER 12.5 mg (bedtime dosing), (2) zaleplon 10 mg (middle-of-the-night dosing), and (3) placebo. Memory testing was conducted before and after an 8-h sleep period, using a word pair association task (WPT; declarative memory) and a finger-tapping task (FTT; procedural memory). RESULTS: ANOVA revealed a significant condition effect for the WPT (p = 0.025) and a trend for the FTT (p = 0.067), which was significant when sex was added to the model (p = 0.014). Improvement in memory performance following sleep was lower with bedtime dosing of zolpidem-ER compared to placebo and middle-of-the-night dosing of zaleplon. There were no differences between placebo and zaleplon. CONCLUSIONS: The results suggest that in some circumstances hypnotics may have the potential to reduce the degree of sleep-dependent memory consolidation and that drug-free sleep early in the night may ameliorate this effect.
Authors: David J Greenblatt; Eric Legangneux; Jerold S Harmatz; Estelle Weinling; Jon Freeman; Kathleen Rice; Gary K Zammit Journal: J Clin Pharmacol Date: 2006-12 Impact factor: 3.126
Authors: Thomas Roth; Catherine Coulouvrat; Goeran Hajak; Matthew D Lakoma; Nancy A Sampson; Victoria Shahly; Alicia C Shillington; Judith J Stephenson; James K Walsh; Ronald C Kessler Journal: Biol Psychiatry Date: 2010-12-31 Impact factor: 13.382
Authors: D J Greenblatt; J S Harmatz; L L von Moltke; B L Ehrenberg; L Harrel; K Corbett; M Counihan; J A Graf; M Darwish; P Mertzanis; P T Martin; W H Cevallos; R I Shader Journal: Clin Pharmacol Ther Date: 1998-11 Impact factor: 6.875
Authors: Matthew P Walker; Tiffany Brakefield; Joshua Seidman; Alexandra Morgan; J Allan Hobson; Robert Stickgold Journal: Learn Mem Date: 2003 Jul-Aug Impact factor: 2.460
Authors: Oluwaseun Akeju; Lauren E Hobbs; Lei Gao; Sara M Burns; Kara J Pavone; George S Plummer; Elisa C Walsh; Tim T Houle; Seong-Eun Kim; Matt T Bianchi; Jeffrey M Ellenbogen; Emery N Brown Journal: Clin Neurophysiol Date: 2017-10-20 Impact factor: 3.708
Authors: Anthony L Gotter; Susan L Garson; Joanne Stevens; Regina L Munden; Steven V Fox; Pamela L Tannenbaum; Lihang Yao; Scott D Kuduk; Terrence McDonald; Jason M Uslaner; Spencer J Tye; Paul J Coleman; Christopher J Winrow; John J Renger Journal: BMC Neurosci Date: 2014-09-22 Impact factor: 3.288